Medical Condition News

RSS

Cancer Research renews call for EU to adopt plain packaging on all tobacco products

On World No Tobacco Day today Cancer Research UK has renewed its call for the European Union (EU) to adopt standardised, plain packaging with graphic pictures of health warnings on all tobacco products.

1 Jun 2011

Diamyd European Phase III study in diabetes does not meet primary endpoint

Diamyd Medical AB reports that the Company has decided not to complete the follow-up period of a European Phase III study with the antigen-based therapy Diamyd.

1 Jun 2011

Patrick K. Donnelly announces official launch of Aptiv Solutions

Chairman and CEO Patrick K. Donnelly today announced the official launch of Aptiv Solutions, a global biopharmaceutical and medical device development services company.

1 Jun 2011

Hospitals facing pressure to hold down costs and cut infections; drug shortages reported

For the first time in its history, Medicare will soon track spending on millions of individual beneficiaries, reward hospitals that hold down costs and penalize those whose patients prove most expensive. The administration plans to establish "Medicare spending per beneficiary" as a new measure of hospital performance, just like the mortality rate for heart attack patients and the infection rate for surgery patients.

1 Jun 2011

U of I scientists team up to examine problem of childhood obesity

University of Illinois scientists from a variety of disciplines have teamed up to examine the factors that contribute to childhood obesity. Why? Because individual researchers have found that the problem is too complicated for any of them to tackle alone.

1 Jun 2011

Innovative bowel screening kits effective in detecting pre-cancerous growths

New bowel screening kits, expected soon for England and Scotland, are more sensitive at picking up pre-cancerous growths in the left-side of the bowel than the right-side because the growths are shaped differently.

1 Jun 2011

Researchers receive CTSI Award for Translational Research in Maternal, Child, and Adolescent Health.

Patricia Dickson, MD, and Jennifer Yee, MD, Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center (LA BioMed) researchers, will be honored on Thursday as recipients of the first UCLA Clinical and Translational Science Institute's (CTSI) Award for Translational Research in Maternal, Child, and Adolescent Health.

1 Jun 2011

Facelift incision with no-neck-scar approach safe and effective for thyroid patients

A facelift incision and robotics can help surgeons safely remove a portion of a diseased thyroid from some patients without the characteristic neck scar.

1 Jun 2011

E64d reduces Aβ levels and improves memory function in brains of Alzheimer's disease mice

Researchers at the University of California, San Diego, the Medical University of South Carolina and American Life Science Pharmaceuticals of San Diego have demonstrated that oral administration of a cysteine protease inhibitor, E64d, not only reduces the build-up of β-amyloid in the brains of animal models for Alzheimer's disease, but also results in a substantial improvement in memory deficit.

1 Jun 2011

Suberoylanilide hydroxamic acid holds promise against familial frontotemporal dementia

A drug already approved for people with cancer shows early potential as a therapy for a common form of dementia, UT Southwestern Medical Center researchers report.

1 Jun 2011

School children with bullying behavior more likely to have sleep-disordered breathing

Children who are bullies or have conduct problems at school, are more likely to be sleepy during the day according to University of Michigan Medical School researchers.

1 Jun 2011

European Commission grants Orphan Drug Designation for CSL Behring's rVIIa-FP to treat hemophilia

CSL Behring announced today that it has been granted Orphan Drug Designations by the European Commission for the development of its recombinant fusion protein linking coagulation factor VIIa with albumin (rVIIa-FP), a novel therapy to treat hemophilia A and hemophilia B patients with inhibitors.

1 Jun 2011

CrystalGenomics begins enrollment in CG100649 Phase 2b osteoarthritis study

CrystalGenomics, Inc. and CG Pharmaceuticals, Inc., a biopharmaceutical company with 3 clinical stage candidates, has announced that the first patient has been enrolled for a Phase 2b clinical study of CG100649, CrystalGenomics' clinical stage novel NSAID candidate, in patients with knee or hip osteoarthritis.

1 Jun 2011

Groundbreaking study identifies neural system responsible for facial recognition

Each time you see a person that you know, your brain rapidly and seemingly effortlessly recognizes that person by his or her face.

1 Jun 2011

Researchers discover new drug target that may effectively prevent onset of Huntington's disease

McMaster University researchers have discovered a new drug target that may be effective at preventing the onset of Huntington's disease, working much the same way heart medications slow the progression of heart disease and reduce heart attacks.

1 Jun 2011

Ampio commences new anti-inflammatory agent Phase 1B trial in osteoarthritis

Ampio Pharmaceuticals, Inc. announced today that it received ethics board approval for a Phase 1B clinical trial in Australia of its biologic anti-inflammatory agent, Ampion.

1 Jun 2011

Bowel cancer strikes early - strikes hard

Recent figures show that the incidence of bowel cancer in young people has surged in the past decade, more than doubling in some age categories. But doctors have been unable to explain the increase.

1 Jun 2011

Centocor Ortho Biotech, AVEO sign license deal to develop, commercialize RON-targeted antibodies

AVEO Pharmaceuticals, Inc. today announced it has entered into an exclusive license agreement with Centocor Ortho Biotech Inc. for the worldwide development and commercialization of AVEO's internally-discovered antibodies targeting the RON receptor.

1 Jun 2011

Chronic fatigue syndrome and mouse virus – no association

An earlier study published in 2009 had claimed that a mouse virus was the cause of chronic fatigue syndrome. New evidence suggests that this assumption is wrong. According to latest evidence the earlier study findings were likely based on contaminated lab samples, US researchers said Tuesday.

1 Jun 2011

Cell phones and cancer – link established

In its latest announcement the World Health Organization (WHO) said that radiation from cell phones can possibly cause cancer. According to the WHO's International Agency for Research on Cancer (IARC), radiofrequency electromagnetic fields have been classified as possibly carcinogenic to humans (group 2B) on the basis of an increased risk for glioma that some studies have associated with the use of wireless phones.

1 Jun 2011

Medical Condition News

Cancer Research renews call for EU to adopt plain packaging on all tobacco products

Diamyd European Phase III study in diabetes does not meet primary endpoint

Patrick K. Donnelly announces official launch of Aptiv Solutions

Hospitals facing pressure to hold down costs and cut infections; drug shortages reported

U of I scientists team up to examine problem of childhood obesity

Innovative bowel screening kits effective in detecting pre-cancerous growths

Researchers receive CTSI Award for Translational Research in Maternal, Child, and Adolescent Health.

Facelift incision with no-neck-scar approach safe and effective for thyroid patients

E64d reduces Aβ levels and improves memory function in brains of Alzheimer's disease mice

Suberoylanilide hydroxamic acid holds promise against familial frontotemporal dementia

School children with bullying behavior more likely to have sleep-disordered breathing

European Commission grants Orphan Drug Designation for CSL Behring's rVIIa-FP to treat hemophilia

CrystalGenomics begins enrollment in CG100649 Phase 2b osteoarthritis study

Groundbreaking study identifies neural system responsible for facial recognition

Researchers discover new drug target that may effectively prevent onset of Huntington's disease

Ampio commences new anti-inflammatory agent Phase 1B trial in osteoarthritis

Bowel cancer strikes early - strikes hard

Centocor Ortho Biotech, AVEO sign license deal to develop, commercialize RON-targeted antibodies

Chronic fatigue syndrome and mouse virus – no association

Cell phones and cancer – link established

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Latest News